Please login to the form below

Not currently logged in
Email:
Password:

Novartis Oncology

This page shows the latest Novartis Oncology news and features for those working in and with pharma, biotech and healthcare.

Novartis launch NET cancer community app

Novartis launch NET cancer community app

Novartis launch NET cancer community app. Galaxies of Hope aims to provide support to cancer patients. ... Ameet Mallik, executive vice president and head of US oncology at Novartis, said: We believe that this app can have a real, positive impact in the

Latest news

More from news
Approximately 3 fully matching, plus 101 partially matching documents found.

Latest Intelligence

  • Charting a course for expansion Charting a course for expansion

    Charting a course for expansion. David Meek on Ipsen's strategic pillars and hopes in oncology. ... Doing so was the latest move in a 25-year pharma career that has also encompassed stints at Johnson &Johnson, Novartis - including a spell as its oncology

  • Choosing destiny Choosing destiny

    For instance, if Novo Nordisk designs a secular grail model by combining IBM's Watson with its own therapies, it will be different from, for example, Novartis' secular grail model combining ... immuno-oncology and companion diagnostics.

  • Deal Watch June 2016 Deal Watch June 2016

    Protein engineering - towards enhanced biologics. Also active in immuno-oncology, Novartis signed a broad collaboration and licence agreement with Xencor worth a potential $2.56bn covering two bispecific, tumour targeting antibodies, ... Tiered low

  • Deal Watch May 2016 Deal Watch May 2016

    Not under pressure as are GSK and Pfizer, Novartis announced the separation of its pharmaceuticals division into two business units: Novartis Oncology and Novartis Pharmaceuticals. ... The pharmaceuticals company will include Novartis' other interests in

  • Pharma deals in June 2015 Pharma deals in June 2015

    This was the case following the $20bn asset swap deal announced in April 2014 in which Novartis and GSK swapped vaccine and oncology assets. ... Licence, collaboration. 364. Spinifex Pharmaceuticals/ Novartis. Lead candidate EMA401 - oral treatment for

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Pfizer’s Elizabeth Barrett joins Novartis as its oncology head Pfizer’s Elizabeth Barrett joins Novartis as its oncology head

    Pfizer’ s Elizabeth Barrett joins Novartis as its oncology head. She succeeds Bruno Strigini who retires. ... Novartis has appointed Elizabeth Barrett to head up its oncology franchise based at the group’s headquarters in Switzerland.

  • Novartis Oncology head Bruno Strigini to retire Novartis Oncology head Bruno Strigini to retire

    Novartis Oncology head Bruno Strigini to retire. Will leave the Swiss pharma firm, and the industry, next year. ... The head of Novartis Oncology Bruno Strigini is set to step down and retire from the pharmaceutical industry.

  • Rainer Boehm and Hervé Hoppenot join Cellectics board Rainer Boehm and Hervé Hoppenot join Cellectics board

    He said: “Despite many advances in oncology, there remains a need to continue to advance the science to meet the needs of its patients. ... Prior to joining Incyte, Hoppenot was the president of Novartis Oncology and has several senior roles with with

  • Alacrita appoints Anna Casse as MD Alacrita appoints Anna Casse as MD

    Prior to BioVault, Casse held several commercial leadership roles including head of Novartis’ophthalmic global business development and licensing, general manager of Novartis’oncology department and she also spent time at

  • Kymab appoints its first chief medical officer Kymab appoints its first chief medical officer

    Kymab appoints its first chief medical officer. Dr Sonia Quaratino joins the firm from Novartis. ... She previous served Novartis as its global clinical programme leader, transitional clinical oncology, with responsibility for the clinical development of

More from appointments
Approximately 1 fully matching, plus 17 partially matching documents found.

Latest from PMHub

  • Igeahub

    Created and curated by Luca Dezzani, MD, Global Medical Director at Novartis Oncology, the Igea blog provides an industry insider’ s view on important topics related to life sciences and healthcare.

  • Marketing strategy in complex environments

    disease. Whilst not new, this approach is becoming increasingly effective for certain therapy areas, particularly  oncology.

More from PMHub
Approximately 0 fully matching, plus 2 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics